2020年10月8日 Certara Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
2020年10月1日 Food and Drug Administration Renews and Expands Use of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
2020年8月13日 Certara Announces First Enrollee in International Registry to Assess Preventative Therapies in Healthcare Workers Exposed to COVID-19